Jun Shibasaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jun Shibasaki has a total of 119 co-authors. Here are the top co-authors by number of shared publications:
Noriko Aida
Department of Radiology, Kanagawa Children's Medical Center, Yokohama, Japan
10 shared publicationsKatsuaki Toyoshima
Department of Neonatology, Kanagawa Children's Medical Center, Yokohama, Japan
7 shared publicationsYasufumi Itani
Department of Neonatology, Kanagawa Children's Medical Center, Yokohama, 232-8555, Japan
7 shared publications- Moyoko Tomiyasu
Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine Baltimore, MD, USA
4 shared publications Akihito Takahashi
Department of Pediatrics Kurashiki Central Hospital Okayama Japan
3 shared publications- Akihito Takeuchi
Division of Neonatology, NHO Okayama Medical Center, Okayama, Japan
3 shared publications
Latest Publications
- 7 February 2023
- Published by Wiley in Acta Paediatrica
- Vol. 112 (4) , 734-741
Prolonged requirements for mechanical ventilation and tube feeding support predicted 18‐month outcomes for neonatal encephalopathy
AimWe evaluated the predictive ability of prolonged requirements for mechanical ventilation or tube feeding support for 18-month composite outcomes in infants with hypoxic-ischaemic encephalopathy treated with hypothermia. MethodsThis retrospective, nationwide, observational study focused on newborn infants registered in Japan's Baby Cooling Registry between 1 January 2012 and 31 December 2016. The adverse outcomes were defined as death or survival with cerebral palsy, visual or auditory impairment or the requirement for mechanical ventilation or tube feeding at 18 months of age. ResultsAdverse outcomes occurred in 165 (28%) of the 591 children in the final cohort. These were predicted by prolonged dependence on mechanical ventilation or tube feeding for more than seven and more than 14 days. The respective values were positive predictive value 0.34 (95% CI 0.33-0.34) and 0.60 (95% CI 0.56-0.62), negative predictive value 0.97 (95% CI 0.91-0.99) and 0.93 (95% CI 0.90-0.95) and area under the curve 0.59 (95% CI 0.54-0.64) and 0.81 (95% CI 0.77-0.85). ConclusionProlonged dependence on mechanical ventilation or tube feeding for more than 14 days may be useful in predicting 18-month outcomes in newborn infants who have received therapeutic hypothermia.
- 7 February 2023
- Published by Wiley in Acta Paediatrica
- Vol. 112 (4) , 734-741
Prolonged requirements for mechanical ventilation and tube feeding support predicted 18‐month outcomes for neonatal encephalopathy
AimWe evaluated the predictive ability of prolonged requirements for mechanical ventilation or tube feeding support for 18-month composite outcomes in infants with hypoxic-ischaemic encephalopathy treated with hypothermia. MethodsThis retrospective, nationwide, observational study focused on newborn infants registered in Japan's Baby Cooling Registry between 1 January 2012 and 31 December 2016. The adverse outcomes were defined as death or survival with cerebral palsy, visual or auditory impairment or the requirement for mechanical ventilation or tube feeding at 18 months of age. ResultsAdverse outcomes occurred in 165 (28%) of the 591 children in the final cohort. These were predicted by prolonged dependence on mechanical ventilation or tube feeding for more than seven and more than 14 days. The respective values were positive predictive value 0.34 (95% CI 0.33-0.34) and 0.60 (95% CI 0.56-0.62), negative predictive value 0.97 (95% CI 0.91-0.99) and 0.93 (95% CI 0.90-0.95) and area under the curve 0.59 (95% CI 0.54-0.64) and 0.81 (95% CI 0.77-0.85). ConclusionProlonged dependence on mechanical ventilation or tube feeding for more than 14 days may be useful in predicting 18-month outcomes in newborn infants who have received therapeutic hypothermia.
- 30 July 2022
- Published by Springer Nature in Pediatric Research
- Vol. 93 (4) , 1057-1063
Predictive value of the Thompson score for short-term adverse outcomes in neonatal encephalopathy
Background To explore the predictive value of the Thompson score during the first 4 days of life for estimating short-term adverse outcomes in neonatal encephalopathy. Methods This observational study evaluated infants with neonatal encephalopathy (≥36 weeks of gestation) registered in a multicenter cohort of cooled infants in Japan. The Thompson score was evaluated at 0–24, 24–48, 48–72, and 72–90 h of age. Adverse outcomes included death, survival with respiratory impairment (requiring tracheostomy), or survival with feeding impairment (requiring gavage feeding) at discharge. Results Of the 632 infants, 21 (3.3%) died, 59 (9.3%) survived with respiratory impairment, and 113 (17.9%) survived with feeding impairment. The Thompson score throughout the first 4 days accurately predicted death, respiratory impairment, or feeding impairment. The 72–90 h score showed the highest accuracy. A cutoff of ≥15 had a sensitivity of 0.85 and specificity of 0.92 for death or respiratory impairment, while a cutoff of ≥14 had a sensitivity of 0.71 and a specificity of 0.92 for death, respiratory or feeding impairment. Conclusion A high Thompson score during the first 4 days of life, especially at 72–90 h could thus be useful for estimating the need for prolonged life support. Impact The Thompson score on days 1–4 of age was useful in predicting death and respiratory or feeding impairments. The 72–90 h Thompson score showed the highest predictive capability. Owing to the rarity of withdrawal of life-sustaining treatment in Japan, 43% of infants with persistent severe encephalopathy with a Thompson score of ≥15 at 72–90 h of age could regain spontaneous breathing, be extubated, and survive without tracheostomy. Meanwhile, approximately 50% of infants who survived without tracheostomy required gavage feeding. Our results could provide useful information for clinical decision making regarding infants with persistent severe encephalopathy.
- 30 July 2022
- Published by Springer Nature in Pediatric Research
- Vol. 93 (4) , 1057-1063
Predictive value of the Thompson score for short-term adverse outcomes in neonatal encephalopathy
Background To explore the predictive value of the Thompson score during the first 4 days of life for estimating short-term adverse outcomes in neonatal encephalopathy. Methods This observational study evaluated infants with neonatal encephalopathy (≥36 weeks of gestation) registered in a multicenter cohort of cooled infants in Japan. The Thompson score was evaluated at 0–24, 24–48, 48–72, and 72–90 h of age. Adverse outcomes included death, survival with respiratory impairment (requiring tracheostomy), or survival with feeding impairment (requiring gavage feeding) at discharge. Results Of the 632 infants, 21 (3.3%) died, 59 (9.3%) survived with respiratory impairment, and 113 (17.9%) survived with feeding impairment. The Thompson score throughout the first 4 days accurately predicted death, respiratory impairment, or feeding impairment. The 72–90 h score showed the highest accuracy. A cutoff of ≥15 had a sensitivity of 0.85 and specificity of 0.92 for death or respiratory impairment, while a cutoff of ≥14 had a sensitivity of 0.71 and a specificity of 0.92 for death, respiratory or feeding impairment. Conclusion A high Thompson score during the first 4 days of life, especially at 72–90 h could thus be useful for estimating the need for prolonged life support. Impact The Thompson score on days 1–4 of age was useful in predicting death and respiratory or feeding impairments. The 72–90 h Thompson score showed the highest predictive capability. Owing to the rarity of withdrawal of life-sustaining treatment in Japan, 43% of infants with persistent severe encephalopathy with a Thompson score of ≥15 at 72–90 h of age could regain spontaneous breathing, be extubated, and survive without tracheostomy. Meanwhile, approximately 50% of infants who survived without tracheostomy required gavage feeding. Our results could provide useful information for clinical decision making regarding infants with persistent severe encephalopathy.
- 1 December 2021
- Published by Elsevier in The Journal of Pediatrics
- Vol. 239, 101-109.e4
Comparison of Predictive Values of Magnetic Resonance Biomarkers Based on Scan Timing in Neonatal Encephalopathy Following Therapeutic Hypothermia
- 1 December 2021
- Published by Elsevier in The Journal of Pediatrics
- Vol. 239, 101-109.e4
Comparison of Predictive Values of Magnetic Resonance Biomarkers Based on Scan Timing in Neonatal Encephalopathy Following Therapeutic Hypothermia
- 15 May 2019
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 105 (1) , 64-68
Outcomes related to 10-min Apgar scores of zero in Japan
Objective Apgar scores of zero at 10 min strongly predict mortality and morbidity in infants. However, recent data reported improved outcomes among infants with Apgar scores of zero at 10 min. We aimed to review the mortality rate and neurodevelopmental outcomes of infants with Apgar scores of zero at 10 min in Japan. Design Observational study. Patients Twenty-eight of 768 infants registered in the Baby Cooling Registry of Japan between 2012 and 2016, at >34 weeks’ gestation, with Apgar scores of zero at 10 min who were treated with therapeutic hypothermia. Interventions We investigated the time of first heartbeat detection in infants with favourable outcomes and who had neurodevelopmental impairments or died. Main outcome measures Clinical characteristics, mortality rate and neurodevelopmental outcomes at 18–22 months of age were evaluated. Results Nine (32%) of the 28 infants died before 18 months of age; 16 (57%) survived, but with severe disabilities and 3 (11%) survived without moderate-to-severe disabilities. At 20 min after birth, 14 of 27 infants (52%) did not have a first heartbeat, 13 of them died or had severe disabilities and one infant, who had the first heartbeat at 20 min, survived without disability. Conclusion Our study adds to the recent evidence that neurodevelopmental outcomes among infants with Apgar scores of zero at 10 min may not be uniformly poor. However, in our study, all infants with their first heartbeat after 20 min of age died or had severe disabilities.
- 15 May 2019
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 105 (1) , 64-68
Outcomes related to 10-min Apgar scores of zero in Japan
Objective Apgar scores of zero at 10 min strongly predict mortality and morbidity in infants. However, recent data reported improved outcomes among infants with Apgar scores of zero at 10 min. We aimed to review the mortality rate and neurodevelopmental outcomes of infants with Apgar scores of zero at 10 min in Japan. Design Observational study. Patients Twenty-eight of 768 infants registered in the Baby Cooling Registry of Japan between 2012 and 2016, at >34 weeks’ gestation, with Apgar scores of zero at 10 min who were treated with therapeutic hypothermia. Interventions We investigated the time of first heartbeat detection in infants with favourable outcomes and who had neurodevelopmental impairments or died. Main outcome measures Clinical characteristics, mortality rate and neurodevelopmental outcomes at 18–22 months of age were evaluated. Results Nine (32%) of the 28 infants died before 18 months of age; 16 (57%) survived, but with severe disabilities and 3 (11%) survived without moderate-to-severe disabilities. At 20 min after birth, 14 of 27 infants (52%) did not have a first heartbeat, 13 of them died or had severe disabilities and one infant, who had the first heartbeat at 20 min, survived without disability. Conclusion Our study adds to the recent evidence that neurodevelopmental outcomes among infants with Apgar scores of zero at 10 min may not be uniformly poor. However, in our study, all infants with their first heartbeat after 20 min of age died or had severe disabilities.
- 1 September 2018
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 288 (3) , 840-848
Changes in Brain Metabolite Concentrations after Neonatal Hypoxic-ischemic Encephalopathy
Time-dependent reductions in N-acetylaspartate plus N-acetylaspartylglutamate and creatine plus phosphocreatine concentrations at both 18–96 hours and 7–14 days after birth accurately predicted death or adverse neurodevelopmental outcomes. Purpose To investigate the time-course changes and predictive utility of brain metabolite concentrations in neonatal hypoxic-ischemic encephalopathy (HIE). Materials and Methods Sixty-eight neonates (age, 35–41 gestational weeks) with HIE were admitted to a neonatal intensive care unit between September 2009 and March 2016 and examined by using proton MR spectroscopy at 18–96 hours (n = 25) and 7–14 days (n = 64) after birth (35–43 postmenstrual weeks) to estimate metabolite concentrations in the deep gray matter. Adverse outcome was defined as death or neurodevelopmental impairment at 18–22 months of age. Areas under the receiver operating characteristic curves were calculated to evaluate the prognostic values of metabolites. Results At 18–96 hours, N-acetylaspartate and creatine concentrations were lower, whereas lactate, and glutamate and glutamine (Glx) concentrations were higher in neonates with adverse outcomes than in those with favorable outcomes. Metabolite concentrations at 18–96 hours decreased...
- 1 September 2018
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 288 (3) , 840-848
Changes in Brain Metabolite Concentrations after Neonatal Hypoxic-ischemic Encephalopathy
Time-dependent reductions in N-acetylaspartate plus N-acetylaspartylglutamate and creatine plus phosphocreatine concentrations at both 18–96 hours and 7–14 days after birth accurately predicted death or adverse neurodevelopmental outcomes. Purpose To investigate the time-course changes and predictive utility of brain metabolite concentrations in neonatal hypoxic-ischemic encephalopathy (HIE). Materials and Methods Sixty-eight neonates (age, 35–41 gestational weeks) with HIE were admitted to a neonatal intensive care unit between September 2009 and March 2016 and examined by using proton MR spectroscopy at 18–96 hours (n = 25) and 7–14 days (n = 64) after birth (35–43 postmenstrual weeks) to estimate metabolite concentrations in the deep gray matter. Adverse outcome was defined as death or neurodevelopmental impairment at 18–22 months of age. Areas under the receiver operating characteristic curves were calculated to evaluate the prognostic values of metabolites. Results At 18–96 hours, N-acetylaspartate and creatine concentrations were lower, whereas lactate, and glutamate and glutamine (Glx) concentrations were higher in neonates with adverse outcomes than in those with favorable outcomes. Metabolite concentrations at 18–96 hours decreased...
- 7 March 2018
- Published by Springer Nature in Journal of Perinatology
- Vol. 38 (6) , 702-707
Blood potassium and urine aldosterone after doxapram therapy for preterm infants
We often encounter infants who developed hypokalaemia following low-dose doxapram for apnea of prematurity (AOP). To determine changes in blood potassium (K+) levels after doxapram administration. We studied infants born before 30 weeks gestation. Doxapram (0.1–0.3 mg/kg/h) in addition to methylxanthines was used to treat AOP refractory to methylxanthines. Twenty-five infants received doxapram were studied. Fifty-two percent developed hypokalemia (<3.0 mEq/L) during doxapram administration. Time after starting doxapram to nadir blood K+ (<3.0 mEq/L) level was 11 days. Blood K+ levels normalized after 5 days of stopping doxapram administration. Data at 10 days before and after and at the time of doxapram administration were, respectively: lowest blood K+ level: 3.9, 3.0, and 3.6 mEq/L; urine aldosterone: 90, 206, and 146 pg/μg creatinine. Blood pH, blood pressure and urine volume were similar. Doxapram-induced hypokalemia may be due to an inappropriate increase in aldosterone levels.
- 7 March 2018
- Published by Springer Nature in Journal of Perinatology
- Vol. 38 (6) , 702-707
Blood potassium and urine aldosterone after doxapram therapy for preterm infants
We often encounter infants who developed hypokalaemia following low-dose doxapram for apnea of prematurity (AOP). To determine changes in blood potassium (K+) levels after doxapram administration. We studied infants born before 30 weeks gestation. Doxapram (0.1–0.3 mg/kg/h) in addition to methylxanthines was used to treat AOP refractory to methylxanthines. Twenty-five infants received doxapram were studied. Fifty-two percent developed hypokalemia (<3.0 mEq/L) during doxapram administration. Time after starting doxapram to nadir blood K+ (<3.0 mEq/L) level was 11 days. Blood K+ levels normalized after 5 days of stopping doxapram administration. Data at 10 days before and after and at the time of doxapram administration were, respectively: lowest blood K+ level: 3.9, 3.0, and 3.6 mEq/L; urine aldosterone: 90, 206, and 146 pg/μg creatinine. Blood pH, blood pressure and urine volume were similar. Doxapram-induced hypokalemia may be due to an inappropriate increase in aldosterone levels.
- Open Access
- 4 January 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 39508
Therapeutic hypothermia for neonatal encephalopathy: a report from the first 3 years of the Baby Cooling Registry of Japan
Therapeutic hypothermia is recommended for moderate and severe neonatal encephalopathy, but is being applied to a wider range of neonates than originally envisaged. To examine the clinical use of therapeutic hypothermia, data collected during the first 3 years (2012–2014) of the Baby Cooling Registry of Japan were analysed. Of 485 cooled neonates, 96.5% were ≥36 weeks gestation and 99.4% weighed ≥1,800 g. Severe acidosis (pH < 7 or base deficit ≥16 mmol/L) was present in 68.9%, and 96.7% required resuscitation for >10 min. Stage II/III encephalopathy was evident in 88.3%; hypotonia, seizures and abnormal amplitude-integrated electroencephalogram were observed in the majority of the remainder. In-hospital mortality was 2.7%; 90.7% were discharged home. Apgar scores and severity of acidosis/encephalopathy did not change over time. The time to reach the target temperature was shorter in 2014 than in 2012. The proportion undergoing whole-body cooling rose from 45.4% to 81.6%, while selective head cooling fell over time. Mortality, duration of mechanical ventilation and requirement for tube feeding at discharge remained unchanged. Adherence to standard cooling protocols was high throughout, with a consistent trend towards cooling being achieved more promptly. The mortality rate of cooled neonates was considerably lower than that reported in previous studies.
- 4 January 2017
- Published by Springer Nature in Scientific Reports
- Vol. 7 (1) , 39508
Open AccessTherapeutic hypothermia for neonatal encephalopathy: a report from the first 3 years of the Baby Cooling Registry of Japan
Therapeutic hypothermia is recommended for moderate and severe neonatal encephalopathy, but is being applied to a wider range of neonates than originally envisaged. To examine the clinical use of therapeutic hypothermia, data collected during the first 3 years (2012–2014) of the Baby Cooling Registry of Japan were analysed. Of 485 cooled neonates, 96.5% were ≥36 weeks gestation and 99.4% weighed ≥1,800 g. Severe acidosis (pH < 7 or base deficit ≥16 mmol/L) was present in 68.9%, and 96.7% required resuscitation for >10 min. Stage II/III encephalopathy was evident in 88.3%; hypotonia, seizures and abnormal amplitude-integrated electroencephalogram were observed in the majority of the remainder. In-hospital mortality was 2.7%; 90.7% were discharged home. Apgar scores and severity of acidosis/encephalopathy did not change over time. The time to reach the target temperature was shorter in 2014 than in 2012. The proportion undergoing whole-body cooling rose from 45.4% to 81.6%, while selective head cooling fell over time. Mortality, duration of mechanical ventilation and requirement for tube feeding at discharge remained unchanged. Adherence to standard cooling protocols was high throughout, with a consistent trend towards cooling being achieved more promptly. The mortality rate of cooled neonates was considerably lower than that reported in previous studies.
- 1 November 2016
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 34 (9) , 1269-1273
Normal lactate concentration range in the neonatal brain
- 1 November 2016
- Published by Elsevier in Magnetic Resonance Imaging
- Vol. 34 (9) , 1269-1273
Normal lactate concentration range in the neonatal brain
- 1 October 2016
- Published by Elsevier in Early Human Development
- Vol. 101, 79-84
Blood pressure and aEEG in the 96h after birth and correlations with neurodevelopmental outcome in extremely preterm infants
- 1 October 2016
- Published by Elsevier in Early Human Development
- Vol. 101, 79-84
Blood pressure and aEEG in the 96h after birth and correlations with neurodevelopmental outcome in extremely preterm infants